Navigation Links
Statins May Help Heart in Some Young Stroke Patients
Date:8/2/2011

TUESDAY, Aug. 2 (HealthDay News) -- Statins, a class of cholesterol-lowering drugs that includes Liptior and Crestor, appear to help young people after they've had a certain kind of stroke with unknown cause, a new study has found.

Strokes are rare in young people, and it's even more uncommon for them to occur without a known cause. In the study, published in the Aug. 2 issue of the journal Neurology, Finnish researchers focused on 215 people who suffered strokes between the ages of 15 and 49 during the years 1994 through 2007.

It wasn't clear why their strokes happened. All were "ischemic," meaning they occurred due to blockage of blood vessels.

The study authors sought to figure out whether being on a statin -- a medication that targets "bad" low-density lipoprotein (LDL) cholesterol -- would help stroke patients avoid heart-related problems, such as heart attack, in the future. They followed the patients for an average of nine years.

After adjusting their statistics so they wouldn't be thrown off by factors such as the study participants' ages or sex, the researchers found that those who took any statins during the follow-up period were 77 percent less likely to experience a heart-related problem than those who didn't.

Twenty-nine heart-related "events" occurred among the 143 patients who never took a statin drug. None occurred among the 36 who always took a statin, and just four events occurred among the 36 patients who took a statin off and on, according to a journal news release.

The authors, Dr. Jukka Putaala of the neurology department at Helsinki University Central Hospital in Finland and colleagues, noted that the study has limitations due to the small number of patients who took the cholesterol drugs and the small number of heart-related problems among them. "Nevertheless, differences between the groups were obvious even within the first years of observation," they wrote.

Commenting on the study, Dr. Larry B. Goldstein, director of the Duke Stroke Center at Duke University Medical Center in Durham, N.C., said that the findings don't directly prove that the cholesterol-fighting medications helped the patients.

Previous research has shown that the medications can reduce the risk of a second stroke, but only in patients with a "bad" cholesterol (LDL-C) level of at least 100 mg/dL, he noted.

"I think it is reasonable, based on the trial data, to consider statins for prevention of recurrent stroke in patients with stroke of unknown cause who have an LDL-C at or above 100 mg/dL, regardless of age," Goldstein said.

More information

For more on stroke, visit the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Larry B. Goldstein, M.D., director, Duke Stroke Center, Duke University Medical Center, Durham, N.C.; Aug. 2, 2011, Neurology


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins May Benefit Prostate Cancer Patients
2. Alternative to Statins Shows Promise
3. Statins may slow progression of multiple sclerosis, new study finds
4. Statins May Slow Progression of Multiple Sclerosis, New Study Finds
5. Do Statins Lower Male Sex Drive?
6. Statins Wont Lower Colon Cancer Risk
7. Statins decrease risk of clot-related diseases
8. Some statins have unintended effects and warrant closer monitoring, study finds
9. Too Many Stroke Patients Go Without Statins
10. MSU team studies connection between statins, tendon ruptures
11. Statins associated with lower cancer recurrence following prostatectomy
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Statins May Help Heart in Some Young Stroke Patients
(Date:9/20/2017)... , ... September 20, 2017 , ... Doctors on Liens ... their qualified network of medical professionals working on a personal injury lien basis. Founded ... Surgery Inc brings these esteemed doctors’ vast experience with orthopedic injuries to patients in ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True ... edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention ... speakers — representing such thought-leading companies as JP Morgan Chase, GE Digital, ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud ... The Guard®, has helped another long-time client pass their Department of Health and ... the law. , Thanks to the help of the Compliancy Group's Audit Response ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t ... risk of price gouging for their prescription drugs, according to a new comparison ... isn’t negotiating on our behalf, there’s no consistency in drug pricing among drug ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)...  Just 18 months after its February 2016 launch, ... the appointment of three new senior people to its ... Jones-Phillips and James Wright bring decades ... Tammy Wynne joins as Director, ... She has over ten years, experience in global market ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology: